Consolidated Statement Of Cash Flows
Japan Animal Referral Medical Center Co.,Ltd. - Filing #7298565
| Concept |
As at 2024-09-30 |
2024-04-01 to 2024-09-30 |
As at 2024-03-31 |
As at 2023-09-30 |
2023-04-01 to 2023-09-30 |
As at 2023-03-31 |
|---|---|---|---|---|---|---|
| Consolidated statement of cash flows | ||||||
| Statement of cash flows | ||||||
| Cash flows from operating activities | ||||||
| Subtotal | — |
645,257,000
JPY
|
— | — |
507,715,000
JPY
|
— |
| Interest and dividends received | — |
125,000
JPY
|
— | — |
19,000
JPY
|
— |
| Income taxes paid | — |
-68,536,000
JPY
|
— | — |
-133,623,000
JPY
|
— |
| Interest paid | — |
-12,131,000
JPY
|
— | — |
-9,489,000
JPY
|
— |
| Net cash provided by (used in) operating activities | — |
565,255,000
JPY
|
— | — |
364,622,000
JPY
|
— |
| Cash flows from investing activities | ||||||
| Purchase of property, plant and equipment | — |
-688,691,000
JPY
|
— | — |
-774,488,000
JPY
|
— |
| Proceeds from sale of property, plant and equipment | — |
JPY
|
— | — |
1,449,000
JPY
|
— |
| Net cash provided by (used in) investing activities | — |
-711,840,000
JPY
|
— | — |
-789,167,000
JPY
|
— |
| Other, net | — |
643,000
JPY
|
— | — |
6,414,000
JPY
|
— |
| Cash flows from financing activities | ||||||
| Proceeds from issuance of shares | — |
8,750,000
JPY
|
— | — |
JPY
|
— |
| Purchase of treasury shares | — |
-172,391,000
JPY
|
— | — |
JPY
|
— |
| Dividends paid | — |
-52,523,000
JPY
|
— | — |
JPY
|
— |
| Proceeds from long-term borrowings | — |
300,000,000
JPY
|
— | — |
489,900,000
JPY
|
— |
| Repayments of long-term borrowings | — |
-340,851,000
JPY
|
— | — |
-290,045,000
JPY
|
— |
| Net cash provided by (used in) financing activities | — |
-262,594,000
JPY
|
— | — |
198,468,000
JPY
|
— |
| Other, net | — |
-1,930,000
JPY
|
— | — |
-1,709,000
JPY
|
— |
| Effect of exchange rate change on cash and cash equivalents | — |
JPY
|
— | — |
JPY
|
— |
| Net increase (decrease) in cash and cash equivalents | — |
-409,179,000
JPY
|
— | — |
-226,076,000
JPY
|
— |
| Cash and cash equivalents |
928,460,000
JPY
|
— |
1,337,639,000
JPY
|
1,589,963,000
JPY
|
— |
1,816,039,000
JPY
|